Vermillion To Report First Quarter 2015 Financial Results And Host Investor Conference Call On May 11

AUSTIN, Texas, April 27, 2015 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today it will report first quarter 2015 financial results after the market close on Monday, May 11, 2015, followed by an investor conference call and webcast at 4:30pm Eastern.

Conference Call & Webcast:

Monday, May 11, 2015 at 4:30pm Eastern/1:30pm Pacific

Domestic:

888-556-4997

International:

719-457-2628

Conference ID:

6696118


Webcast: http://public.viavid.com/player/index.php?id=114376


Replay - Available through May 25, 2015

Domestic:

877-870-5176

International:

858-384-5517

Conference ID:

6696118

About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, have diagnostic programs in gynecologic disease. The company’s lead diagnostic, OVA1®, is a blood test for pre-surgical assessment of ovarian tumors for malignancy, using an innovative algorithmic approach. As the first FDA-cleared, protein-based In Vitro Diagnostic Multivariate Index Assay, OVA1 represents a new class of software-based diagnostics. For additional information, including published clinical trials, visit www.vermillion.com.

Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
Tel 1-646-597-6983
mwood@lifesciadvisors.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vermillion-to-report-first-quarter-2015-financial-results-and-host-investor-conference-call-on-may-11-300072034.html

SOURCE Vermillion, Inc.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC